Fuming Xu

1.4k total citations
11 papers, 762 citations indexed

About

Fuming Xu is a scholar working on Molecular Biology, Organic Chemistry and Pathology and Forensic Medicine. According to data from OpenAlex, Fuming Xu has authored 11 papers receiving a total of 762 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Molecular Biology, 3 papers in Organic Chemistry and 3 papers in Pathology and Forensic Medicine. Recurrent topics in Fuming Xu's work include Protein Degradation and Inhibitors (4 papers), Cancer Mechanisms and Therapy (3 papers) and Ubiquitin and proteasome pathways (3 papers). Fuming Xu is often cited by papers focused on Protein Degradation and Inhibitors (4 papers), Cancer Mechanisms and Therapy (3 papers) and Ubiquitin and proteasome pathways (3 papers). Fuming Xu collaborates with scholars based in China and United States. Fuming Xu's co-authors include Shaomeng Wang, Wenfang Xu, Chao‐Yie Yang, Jiantao Hu, Donna McEachern, Longchuan Bai, Yujun Zhao, Liu Liu, Bo Wen and Zhuo Chen and has published in prestigious journals such as Journal of Medicinal Chemistry, European Journal of Medicinal Chemistry and Current Medicinal Chemistry.

In The Last Decade

Fuming Xu

11 papers receiving 751 citations

Peers

Fuming Xu
Emanuela Capota United States
Roberta Pireddu United States
Jeremy L. Yap United States
Qiuping Xiang China
Franziska Wachter United States
Jacob I. Contreras United States
Mingxing Teng United States
Rosemary Burke United Kingdom
Angela Hayes United Kingdom
Matteo Rossi Sebastiano Italy
Emanuela Capota United States
Fuming Xu
Citations per year, relative to Fuming Xu Fuming Xu (= 1×) peers Emanuela Capota

Countries citing papers authored by Fuming Xu

Since Specialization
Citations

This map shows the geographic impact of Fuming Xu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fuming Xu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fuming Xu more than expected).

Fields of papers citing papers by Fuming Xu

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fuming Xu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fuming Xu. The network helps show where Fuming Xu may publish in the future.

Co-authorship network of co-authors of Fuming Xu

This figure shows the co-authorship network connecting the top 25 collaborators of Fuming Xu. A scholar is included among the top collaborators of Fuming Xu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fuming Xu. Fuming Xu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

11 of 11 papers shown
1.
Hu, Biao, Fuming Xu, Mi Wang, et al.. (2023). Precise Conformational Control Yielding Highly Potent and Exceptionally Selective BRD4 Degraders with Strong Antitumor Activity. Journal of Medicinal Chemistry. 66(12). 8222–8237. 16 indexed citations
2.
Hu, Jiantao, Biao Hu, Mingliang Wang, et al.. (2019). Discovery of ERD-308 as a Highly Potent Proteolysis Targeting Chimera (PROTAC) Degrader of Estrogen Receptor (ER). Journal of Medicinal Chemistry. 62(3). 1420–1442. 192 indexed citations
3.
Zhou, Bing, Jiantao Hu, Fuming Xu, et al.. (2017). Discovery of a Small-Molecule Degrader of Bromodomain and Extra-Terminal (BET) Proteins with Picomolar Cellular Potencies and Capable of Achieving Tumor Regression. Journal of Medicinal Chemistry. 61(2). 462–481. 283 indexed citations
4.
Liang, Xuewu, Fuming Xu, Xiaoguang Li, et al.. (2014). VEGF Signal System: The Application of Antiangiogenesis. Current Medicinal Chemistry. 21(7). 894–910. 43 indexed citations
5.
Zhang, Lei, Yantao Han, Qixiao Jiang, et al.. (2014). Trend of Histone Deacetylase Inhibitors in Cancer Therapy: Isoform Selectivity or Multitargeted Strategy. Medicinal Research Reviews. 35(1). 63–84. 112 indexed citations
6.
Xu, Fuming, Yuping Jia, Xuejian Wang, et al.. (2013). Synthesis and biological evaluation of N-(4-hydroxy-3-mercaptonaphthalen-1-yl)amides as inhibitors of angiogenesis and tumor growth. European Journal of Medicinal Chemistry. 64. 377–388. 27 indexed citations
7.
Xu, Fuming, Lei Zhang, Yuping Jia, et al.. (2013). Discovery of 4-amino-2-(thio)phenol derivatives as novel protein kinase and angiogenesis inhibitors for the treatment of cancer: Synthesis and biological evaluation. Part II. European Journal of Medicinal Chemistry. 69. 191–200. 11 indexed citations
8.
9.
Jia, Yuping, et al.. (2013). Design, Synthesis and Biological Evaluation of Pazopanib Derivatives as Antitumor Agents. Chemical Biology & Drug Design. 83(3). 306–316. 50 indexed citations
10.
Zhang, Lei, Xuejian Wang, Jinhong Feng, et al.. (2012). Discovery of Novel Vascular Endothelial Growth Factor Receptor 2 Inhibitors: A Virtual Screening Approach. Chemical Biology & Drug Design. 80(6). 893–901. 7 indexed citations
11.
Wang, Qiang, Fuming Xu, Jian Zhang, et al.. (2010). Design, Synthesis and Preliminary Activity Evaluation of Novel L-Lysine Derivatives as Aminopeptidase N/CD13 Inhibitors. Protein and Peptide Letters. 17(7). 847–853. 3 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Emanuela Capota Breakdown of academic impact, for papers by Roberta Pireddu Breakdown of academic impact, for papers by Jeremy L. Yap Breakdown of academic impact, for papers by Qiuping Xiang Breakdown of academic impact, for papers by Franziska Wachter Breakdown of academic impact, for papers by Jacob I. Contreras Breakdown of academic impact, for papers by Mingxing Teng Breakdown of academic impact, for papers by Rosemary Burke Breakdown of academic impact, for papers by Angela Hayes Breakdown of academic impact, for papers by Matteo Rossi Sebastiano
Rankless by CCL
2026